Schnakenberg, Rieke
Silies, Katharina
Berg, Almuth
Kirchner, Änne
Langner, Henriette
Chuvayaran, Yuliya
Köberlein-Neu, Juliane
Haastert, Burkhard
Wiese, Birgitt
Meyer, Gabriele
Köpke, Sascha
Hoffmann, Falk
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GL1707A-D)
Article History
Received: 11 November 2019
Accepted: 25 March 2020
First Online: 17 April 2020
Ethics approval and consent to participate
: The STADPLAN study was approved by the Ethics Committees of the Medical Faculties of the Universities of the Martin Luther University Halle-Wittenberg (no. 2019–045), the Carl von Ossietzky University Oldenburg (no. 2019–024), and the University of Lübeck, Germany in a joint approval. In the case of important protocol modifications, the above mentioned Ethics Committees as well as the funding institution will be informed immediately. Written informed consent was obtained from each participating patient before the start of the trial.Although a cognitive decline was an exclusion criterion in our study (see the “In- and exclusion criteria for patients” subheading), we additionally provided an information- and ethical consent for participation sheet for legal guardians or representatives.
: Not applicable.
: The authors declare that they have no competing interests.